Individualized Ofatumumab versus Fixed Low-Dose Rituximab in MuSK-Antibody-Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
PURPOSE This study aimed to compare the effectiveness and safety of ofatumumab (OFA) versus rituximab (RTX) in patients with muscle-specific kinase myasthenia gravis (MuSK-MG). METHODS This multicenter retrospective cohort study included 17 OFA-treated and 10 RTX-treated MuSK-MG patients from 3 centers. The individua...